1. Home
  2. ICUI vs SBSW Comparison

ICUI vs SBSW Comparison

Compare ICUI & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • SBSW
  • Stock Information
  • Founded
  • ICUI 1984
  • SBSW 2013
  • Country
  • ICUI United States
  • SBSW South Africa
  • Employees
  • ICUI N/A
  • SBSW N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • SBSW Precious Metals
  • Sector
  • ICUI Health Care
  • SBSW Basic Materials
  • Exchange
  • ICUI Nasdaq
  • SBSW Nasdaq
  • Market Cap
  • ICUI 3.4B
  • SBSW 3.2B
  • IPO Year
  • ICUI 1992
  • SBSW N/A
  • Fundamental
  • Price
  • ICUI $134.86
  • SBSW $6.09
  • Analyst Decision
  • ICUI Strong Buy
  • SBSW Hold
  • Analyst Count
  • ICUI 5
  • SBSW 4
  • Target Price
  • ICUI $196.75
  • SBSW $5.05
  • AVG Volume (30 Days)
  • ICUI 283.6K
  • SBSW 10.6M
  • Earning Date
  • ICUI 05-08-2025
  • SBSW 06-10-2025
  • Dividend Yield
  • ICUI N/A
  • SBSW N/A
  • EPS Growth
  • ICUI N/A
  • SBSW N/A
  • EPS
  • ICUI N/A
  • SBSW N/A
  • Revenue
  • ICUI $2,420,093,000.00
  • SBSW $5,938,469,800.00
  • Revenue This Year
  • ICUI N/A
  • SBSW $8.03
  • Revenue Next Year
  • ICUI N/A
  • SBSW $2.88
  • P/E Ratio
  • ICUI N/A
  • SBSW N/A
  • Revenue Growth
  • ICUI 7.22
  • SBSW N/A
  • 52 Week Low
  • ICUI $101.44
  • SBSW $3.05
  • 52 Week High
  • ICUI $196.26
  • SBSW $6.27
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 48.47
  • SBSW 71.12
  • Support Level
  • ICUI $127.91
  • SBSW $4.52
  • Resistance Level
  • ICUI $135.62
  • SBSW $6.27
  • Average True Range (ATR)
  • ICUI 4.35
  • SBSW 0.20
  • MACD
  • ICUI -0.26
  • SBSW 0.10
  • Stochastic Oscillator
  • ICUI 33.77
  • SBSW 89.71

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

Share on Social Networks: